Low-attenuation Coronary Plaque Burden May Become Next Big Cardiac Risk Assessment
There is a promising recent development in cardiovascular computed tomography angiography (CCTA) to analyze plaque to more accurately assess the risk of myocardial infarction (MI), determining which patients to put on aspirin and statins and to have the ability to monitor reversal of coronary inflammation using various drugs. This new plaque assessment technology, the fat attenuation index (FAI), was a big topic of discussion and one of the main take aways from the Society of Cardiovascular Computed Tomography (SCCT) 2020 virtual meting in July.
You are able to read the full article here.
BREAKING BOUNDARIES: 15 HEALTH CARE STARTUPS IN OXFORDSHIRE TAKING THE WORLD BY STORM
The health care startup scene in Oxford, Oxfordshire, United Kingdom, is thriving with innovative companies that are making a significant…
New Cardiac Disease Diagnostic Technology Piloting in the UK
The new pilot supported by NHS England will involve five NHS trusts, including University Hospitals of Leicester NHS Trust, Liverpool…